SIGA (SIGA) Q1 2026 Earnings Call Transcript
Image source: The Motley Fool.DATEThursday, May 7, 2026 at 4:30 p.m. ETCALL PARTICIPANTSChief Executive Officer — Diem NguyenChief Financial Officer…
£15,161
2,61%
Echtzeit-Aktienkurs HIKMA PHARMACEUTIC.LS-,10
Bid:
Ask:
Nachrichten zur HIKMA PHARMACEUTIC.LS-,10 Aktie
Hikma Pharmaceuticals PLC (HKMPY) Q4 2025 Earnings Call Transcript
…
Hikma Pharma tumbles on softer guidance as buyback fails to soften pill
Hikma Pharmaceuticals PLC shares fell almost 16% to 1,390p after the drugs group delivered results for 2025 in line with forecasts but…
Hikma falls to three-year low as CEO steps down with immediate effect
Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) shares fell 1.45p to 1,494p, its lowest since late 2022, on news that Riad Mishlawi is stepping…
Hikma Pharmaceuticals: Due a dose of confidence
After a rough six months in which its shares have shed a quarter of their value, Hikma Pharmaceuticals PLC (LSE:HIK,…
Hikma Pharma tumbles as injectables guidance cut
Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) shares fell almsot 13% to 1,547p after the generic drug manufacturer lowered medium-term guidance for its...…
If Hikma can reassure with quarterly update it should be catalyst, says broker
If Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) can deliver a reassuring third-quarter trading update next week, broker Panmure Liberum it could start to...…
Hikma Pharma tumbles as first-half profits dented by shifting product mix
Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) was the biggest faller on the FTSE 100 on Thursday morning after the drugmakers interim results…
Hikma Pharmaceuticals to report H1 2025 results on August 7 By Investing.com
Hikma Pharmaceuticals to report H1 2025 results on August 7…
Hikma Pharma jumps as it hikes medium-term outlook
Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) saw its shares jump 8% after it put out a midday update on its outlook, seeing…
Hikma Pharmaceuticals gets ’BBB’ rating upgrade from S&P on strong momentum By Investing.com
Hikma Pharmaceuticals gets ’BBB’ rating upgrade from S&P on strong momentum…
AXSM Settles Sunosi Patent Litigation With Hikma Pharmaceuticals
Axsome enters into a settlement agreement with Hikma Pharmaceuticals to resolve a patent litigation related to Sunosi.…
Hikma shares fall 5% as stock succumbs to profit taking after strong results and outlook statement
Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) shares fell five per cent in early trading as investors took profits despite the company…
Investing in Hikma Pharmaceuticals (LON:HIK) five years ago would have delivered you a 38% gain
Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make...…
Hikma Pharmaceuticals PLC (HKMPF) Q2 2024 Pre-Recorded Presentation Transcript
…
Hikma Pharmaceuticals shares surge on upbeat guidance By Investing.com
Hikma Pharmaceuticals shares surge on upbeat guidance…
Hikma Pharmaceuticals rallies following bullish first-half earnings
Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) shares bounced 7.6% higher on Thursday following publication of its half-year financial report. “We had…
Hikma Pharma buys Xellia assets for US$135m
Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) has bought a raft of US injectable or finished dosage form (FDF) assets from Copenhagen-based…
Hikma beefs up complex manufacturing skillset with Xellia assets
Hikma Pharmaceuticals has bought a raft of US injectable or finished dosage form (FDF) assets from Copenhagen-based Xellia Pharmaceuticals for US$135...…